Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Neurosci.
Sec. Cellular Neuropathology
Volume 18 - 2024 | doi: 10.3389/fncel.2024.1458475
This article is part of the Research Topic Recent Advances in Mitochondrial Dysfunction and Therapeutics for Neurodegeneration and Aging View all 4 articles

CoA Synthase Plays a Critical Role in Neurodevelopment and Neurodegeneration

Provisionally accepted
Chiara Cavestro Chiara Cavestro 1Marco D'Amato Marco D'Amato 1Maria Nicol Colombo Maria Nicol Colombo 1Floriana Cascone Floriana Cascone 1Andrea Stefano Moro Andrea Stefano Moro 2Sonia Levi Sonia Levi 2,3Valeria Tiranti Valeria Tiranti 1*Ivano Di Meo Ivano Di Meo 1
  • 1 Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
  • 2 Vita-Salute San Raffaele University, Milan, Lombardy, Italy
  • 3 Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy

The final, formatted version of the article will be published soon.

    Background: Coenzyme A (CoA), which is widely distributed and vital for cellular metabolism, is a critical molecule essential in both synthesizing and breaking down key energy sources in the body. Inborn errors of metabolism in the cellular de novo biosynthetic pathway of CoA have been linked to human genetic disorders, emphasizing the importance of this pathway. The COASY gene encodes the bifunctional enzyme CoA synthase, which catalyzes the last two reactions of the CoA biosynthetic pathway and serves as one of the rate-limiting components of the pathway. Recessive variants of this gene cause an exceptionally rare and devastating disease called COASY protein-associated neurodegeneration (CoPAN) while complete loss-of-function variants in COASY have been identified in fetuses/neonates with Pontocerebellar Hypoplasia type 12 (PCH 12). Understanding why the different symptoms emerge in these disorders and what determines the development of one syndrome over the other is still not achieved. To shed light on the pathogenesis, we generated a new conditional animal model in which Coasy was deleted under the control of the human GFAP promoter. We used this mouse model to investigate how defects in the CoA biosynthetic pathway affect brain development. This model showed a broad spectrum of severity of the in vivo phenotype, ranging from very short survival (less than 2 weeks) to normal life expectancy in some animals. Surviving mice displayed a behavioral phenotype with sensorimotor defects. Ex vivo histological analysis revealed variable but consistent cerebral and cerebellar cortical hypoplasia, in parallel with a broad astrocytic hyper-proliferation in the cerebral cortex. In addition, primary astrocytes derived from this model exhibited lipid peroxidation, iron dyshomeostasis, and impaired mitochondrial respiration. Notably, Coasy ablation in radial glia and astrocytic lineage triggers abnormal neuronal development and chronic neuroinflammation, offering new insights into disease mechanisms.

    Keywords: CoA synthase, COASY Protein-Associated Neurodegeneration, pontocerebellar hypoplasia type 12, neurodegeneration, neurodevelopment, Animal Models

    Received: 02 Jul 2024; Accepted: 27 Aug 2024.

    Copyright: © 2024 Cavestro, D'Amato, Colombo, Cascone, Moro, Levi, Tiranti and Di Meo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Valeria Tiranti, Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.